Results 11 to 20 of about 52,212 (193)

The Prevalence of Peripheral Erythrophagocytosis in Pediatric Immune-Mediated Hemolytic Anemia [PDF]

open access: yesHematology Reports
Background: Peripheral erythrophagocytosis appears to be a unique sign of acquired immune-mediated hemolytic anemia. It is said to be rare but its prevalence among patients with autoimmune hemolytic anemia has not been studied.
Anselm Chi-wai Lee
doaj   +2 more sources

A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report [PDF]

open access: yesFrontiers in Immunology
Contrast medium is frequently associated with allergic reactions and kidney dysfunction. However, contrast media can induce hemolytic anemia with a broad spectrum of hemolytic manifestations.
Sabine Hermann   +6 more
doaj   +2 more sources

Autoimmune hemolytic anemia [PDF]

open access: yesHematology, 2018
AbstractThe diagnosis of autoimmune hemolytic anemia (AIHA) can be made with a stepwise approach that aims to identify laboratory and clinical evidence of hemolysis and then determine the immune nature of hemolysis with the direct anti-globulin test. Once alternative causes for these findings have been excluded, AIHA is established, and the clinician ...
Quentin A. Hill, Anita J. Hill
openaire   +3 more sources

Acute Brucellosis Presenting as an Autoimmune Hemolytic Anemia

open access: yesCase Reports in Infectious Diseases, 2018
Brucellosis is one of the most widespread zoonosis in the world. Hematological complications in brucellosis usually present as mild anemia, leukopenia, or pancytopenia. Autoimmune hemolytic anemia in brucellosis is rarely reported.
Durga Shankar Meena   +3 more
doaj   +1 more source

Immune hemolytic anemia in a patient with tuberculous lymphadenitis

open access: yesJournal of Global Infectious Diseases, 2011
Anemia in tuberculosis is usually anemia of chronic disease. Severe hemolytic anemia is exceedingly rare in tuberculosis patients. We report a patient diagnosed with tubercular lymphadenitis complicated by Coomb′s positive hemolytic anemia.
Manjunath Nandennavar   +3 more
doaj   +1 more source

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease

open access: yesFrontiers in Pediatrics, 2020
Objective: We assessed the risk of IVIG-associated hemolytic anemia in patients with acute Kawasaki disease (KD) and evaluated the risk of weight-based dosing in our obese patients.Methods: IVIG-associated hemolytic anemia was assessed in acute KD ...
Khanh-Van Y. Van Anh   +2 more
doaj   +1 more source

Complement inhibitors to treat IgM-mediated autoimmune hemolysis

open access: yesHaematologica, 2015
Complement activation in autoimmune hemolytic anemia may exacerbate extravascular hemolysis and may occasionally result in intravascular hemolysis. IgM autoantibodies as characteristically found in cold autoantibody autoimmune hemolytic anemia, in cold ...
Diana Wouters, Sacha Zeerleder
doaj   +1 more source

Donath-landsteiner hemolytic anemia with erythrophagocytosis and platelet phagocytosis in peripheral smear: Rare findings

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
The Donath-Landsteiner (DL) hemolytic anemia or paroxysmal cold hemoglobinuria (PCH) is a rare subtype of autoimmune hemolytic anemia (AIHA). We report here a case of a 22-year-old young female who presented with acute onset shortness of breath.
Majed Abdul Basit Momin   +2 more
doaj   +1 more source

Mixed autoimmune hemolytic anemia in a 2-year-old girl

open access: yesJournal of Applied Hematology, 2023
Immune hemolytic anemia is diagnosed when it exhibits the clinical symptoms and laboratory findings of hemolytic anemia, such as pallor, jaundice, anemia, high indirect bilirubin, increased reticulocyte count, and a positive direct antiglobulin test ...
Asim Abdullah Alamri   +5 more
doaj   +1 more source

Hemolytic anemia caused by alectinib, an Anaplastic Lymphoma Kinase (ALK) inhibitor: A case report

open access: yesCurrent Problems in Cancer: Case Reports, 2022
Background: Anaplastic Lymphoma Kinase (ALK) inhibitors are tyrosine kinase inhibitors used as molecular-targeted therapy for non-small cell lung cancers (NSCLC) harbouring ALK translocations.
Robina Aerts   +6 more
doaj  

Home - About - Disclaimer - Privacy